U.S. Imposes 100% Section 232 Tariffs on Patented Pharmaceuticals and Ingredients

2026-04-03T01:30:07+00:00April 3rd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

New U.S. Section 232 pharmaceutical tariffs introduce a 100% duty on patented drugs and APIs beginning in 2026, with tiered rates tied to onshoring and pricing agreements. While generics and specialty medicines remain exempt, companies can reduce tariffs to 0% through MFN pricing and domestic manufacturing commitments, signaling a major shift in global pharmaceutical supply chains and U.S. trade policy.

CIT Orders CBP to Process IEEPA Refunds; Order Expanded But Pause Continued

2026-03-22T14:01:51+00:00March 22nd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

On March 20, 2026, the U.S. Court of International Trade expanded its IEEPA refund order to include tariffs on Brazil and India but continued the pause on immediate enforcement. CBP is developing the ACE CAPE system to handle electronic submission, validation, and processing of IEEPA tariff refund claims for importers nationwide.

Register for CBP TRLED Webinars on Trade Violation Reporting (Mar 31 and April 2 Sessions Cancelled)

2026-03-22T14:11:34+00:00March 22nd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

The U.S. Customs and Border Protection (CBP) will host FY 2026 TRLED webinars on trade violation reporting. Sessions cover the Trade Violations Reporting tool and EAPA allegation filings. Due to a partial DHS shutdown, the March 31 and April 2 webinars are canceled. Registration is required for remaining sessions later this year.

USTR Launches Section 301 Investigations Into Forced Labor in 60 Economies

2026-03-17T18:16:19+00:00March 17th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs, U.S. Tariffs, United States Imports|

The United States Trade Representative has initiated Section 301 investigations into 60 economies over failure to enforce bans on goods produced with forced labor. The review will assess whether these practices burden U.S. commerce. Public comments are due April 15, 2026, with hearings scheduled for April 28 as consultations begin.

U.S. Launches Section 301 Investigations into Global Manufacturing Overcapacity

2026-03-17T14:20:03+00:00March 17th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs, U.S. Tariffs, United States Imports|

The U.S. Trade Representative has initiated Section 301 investigations into structural excess manufacturing capacity in 16 economies, including China, the European Union, and Mexico. The review will assess whether foreign acts or policies unfairly burden or restrict U.S. commerce. Public comments open March 17, 2026.

U.S. Imposes 10% Temporary Import Surcharge Under Section 122 (Updated)

2026-02-25T03:21:21+00:00February 25th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs, U.S. Tariffs, United States Imports|

Following the Supreme Court decision on Feb. 20, 2026, the administration implemented a temporary 10% import surcharge under Section 122, effective Feb. 24. The measure targets persistent U.S. balance-of-payments deficits and dollar pressures. CBP issued guidance detailing affected imports, exemptions, and reporting requirements.

Go to Top